Pfeiffenberger Brent's Form 4 filing
Century Therapeutics, Inc. (IPSC) · filed Sep 9, 2026
- Accession no.
- 0002001162-26-000016
- Filed
- Sep 9, 2026, 4:36 PM ET
- Trade date
- Sep 4, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pfeiffenberger BrentCIK 0002001162 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | FTax withholdingDisposed | −463 | $2.11 | −$976.93 | 3,633,839 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.